Intellectual Property India Publishes Patent Application for 'New N Heteroarylbenzamides Derivatives As Flt3 Inhibitors' Filed by Biodol Therapeutics; Inserm (Institut National De La Sante Et De La Recherche Medicale); Centre National De La Recherche Scientifique; Universite De Montpellier; and Universite De Strasbourg

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517034044 A) filed by Biodol Therapeutics; Inserm (Institut National De La Sante Et De La Recherche Medicale); Centre National De La Recherche Scientifique; Universite De Montpellier; and Universite De Strasbourg, Montarnaud, France, on April 7, for 'new n heteroarylbenzamides derivatives as flt3 inhibitors.'

Inventor(s) include Mornat Pauline; Sokoloff Pierre; and Rognan Didier.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a compound of formula (I) or any of its acceptable salts (I) wherein W X Y and Z e...